DK314586D0 - Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler - Google Patents

Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler

Info

Publication number
DK314586D0
DK314586D0 DK314586A DK314586A DK314586D0 DK 314586 D0 DK314586 D0 DK 314586D0 DK 314586 A DK314586 A DK 314586A DK 314586 A DK314586 A DK 314586A DK 314586 D0 DK314586 D0 DK 314586D0
Authority
DK
Denmark
Prior art keywords
small cell
residues
human
lungcarcinomes
antigens
Prior art date
Application number
DK314586A
Other languages
English (en)
Other versions
DK314586A (da
DK170619B1 (da
Inventor
Ingegerd Hellstrom
Joseph Patrick Brown
Karl Erik Hellstrom
Diane Horn
Peter Linsley
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of DK314586D0 publication Critical patent/DK314586D0/da
Publication of DK314586A publication Critical patent/DK314586A/da
Application granted granted Critical
Publication of DK170619B1 publication Critical patent/DK170619B1/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK314586A 1984-11-02 1986-07-02 Monoklonale antistoffer og fragmenter deraf med antigener knyttet til humane ikke-småcellede lungecarcinomer DK170619B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US66752184A 1984-11-02 1984-11-02
US66752184 1984-11-02
US78517785A 1985-10-07 1985-10-07
US78517785 1985-10-07
PCT/US1985/002132 WO1986002735A1 (en) 1984-11-02 1985-10-30 Monoclonal antibodies and antigens for human non-small cell lung carcinomas
US8502132 1985-10-30

Publications (3)

Publication Number Publication Date
DK314586D0 true DK314586D0 (da) 1986-07-02
DK314586A DK314586A (da) 1986-09-01
DK170619B1 DK170619B1 (da) 1995-11-13

Family

ID=27099700

Family Applications (1)

Application Number Title Priority Date Filing Date
DK314586A DK170619B1 (da) 1984-11-02 1986-07-02 Monoklonale antistoffer og fragmenter deraf med antigener knyttet til humane ikke-småcellede lungecarcinomer

Country Status (21)

Country Link
EP (2) EP0207090B1 (da)
JP (3) JPH0675514B2 (da)
KR (1) KR910000903B1 (da)
AT (1) ATE117089T1 (da)
AU (1) AU599578B2 (da)
DE (1) DE3587976T2 (da)
DK (1) DK170619B1 (da)
ES (1) ES8704735A1 (da)
FI (1) FI85814C (da)
GB (1) GB2182949B (da)
GR (1) GR852622B (da)
HU (1) HU208546B (da)
IE (1) IE58590B1 (da)
IL (1) IL76877A (da)
NO (1) NO862690D0 (da)
NZ (1) NZ214055A (da)
OA (1) OA08354A (da)
PH (1) PH24961A (da)
PT (1) PT81418B (da)
WO (1) WO1986002735A1 (da)
YU (1) YU46386B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708930A (en) * 1984-11-09 1987-11-24 Coulter Corporation Monoclonal antibody to a human carcinoma tumor associated antigen
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
JPS61258173A (ja) * 1985-05-10 1986-11-15 Akira Taniuchi モノクロ−ナル抗体およびその製法ならびに用途
AU601680B2 (en) * 1985-05-28 1990-09-20 Joseph P. Brown Monoclonal antibodies for human non-small cell lung carcinomas
US5185432A (en) * 1986-02-26 1993-02-09 Oncogen Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas
JPS6319561A (ja) * 1986-07-11 1988-01-27 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺癌単クロ−ン性抗体
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
DK35189A (da) * 1988-01-29 1989-07-31 Lilly Co Eli Forbindelser indeholdende rekombinant dna, vektorer omfattende disse forbindelser samt fremgangsmaade til udtrykkelse af et humant adenocarcinoma-antigen
AU632469B2 (en) * 1988-04-04 1993-01-07 Johns Hopkins University, The A method for early detection of lung cancer
US5171665A (en) * 1989-04-17 1992-12-15 Oncogen Monoclonal antibody to novel antigen associated with human tumors
IT1264490B (it) * 1992-02-17 1996-09-24 Uni Degli Studi G D Annunzio C Antigene 90k associato a tumori.
JPH0727604U (ja) * 1993-06-18 1995-05-23 修司 坂本 磁気治療具
EP0695760A1 (en) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Novel tumor marker for lung cancer
DE202012001863U1 (de) 2012-02-22 2012-03-19 Haldex Brake Products Ab Scheibenbremse und Sensoreinrichtung hierfür

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
JPS61258173A (ja) * 1985-05-10 1986-11-15 Akira Taniuchi モノクロ−ナル抗体およびその製法ならびに用途
AU601680B2 (en) * 1985-05-28 1990-09-20 Joseph P. Brown Monoclonal antibodies for human non-small cell lung carcinomas

Also Published As

Publication number Publication date
FI862821L (fi) 1986-07-02
GB2182949A (en) 1987-05-28
IE58590B1 (en) 1993-10-20
ES8704735A1 (es) 1987-04-16
KR910000903B1 (ko) 1991-02-12
JPH06340699A (ja) 1994-12-13
DE3587976D1 (de) 1995-02-23
GB2182949B (en) 1989-05-24
PH24961A (en) 1990-12-26
JPH0733400B2 (ja) 1995-04-12
IL76877A0 (en) 1986-02-28
JP2567564B2 (ja) 1996-12-25
KR880700268A (ko) 1988-02-22
ATE117089T1 (de) 1995-01-15
DK314586A (da) 1986-09-01
IL76877A (en) 1991-11-21
GR852622B (da) 1986-03-04
AU5069185A (en) 1986-05-15
PT81418B (pt) 1987-11-11
EP0207090B1 (en) 1995-01-11
DK170619B1 (da) 1995-11-13
AU599578B2 (en) 1990-07-26
JPS62501955A (ja) 1987-08-06
NZ214055A (en) 1991-06-25
JPH0675514B2 (ja) 1994-09-28
EP0566066A1 (en) 1993-10-20
EP0207090A4 (en) 1988-04-26
HUT43188A (en) 1987-09-28
FI85814C (fi) 1992-06-10
IE852681L (en) 1986-05-02
FI862821A0 (fi) 1986-07-02
PT81418A (en) 1985-11-01
JPH06296497A (ja) 1994-10-25
ES548421A0 (es) 1987-04-16
YU172185A (en) 1989-08-31
HU208546B (en) 1993-11-29
FI85814B (fi) 1992-02-28
NO862690D0 (no) 1986-07-02
YU46386B (sh) 1993-10-20
WO1986002735A1 (en) 1986-05-09
OA08354A (en) 1988-02-29
GB8616219D0 (en) 1986-08-13
DE3587976T2 (de) 1995-05-18
EP0207090A1 (en) 1987-01-07

Similar Documents

Publication Publication Date Title
DK314586D0 (da) Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler
Butkowski et al. Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen.
Jander et al. A collagen-like glycoprotein of the extracellular matrix is the undegraded form of type VI collagen
KR950704489A (ko) 인터페론 타우 조성물 및 사용방법(interferon tau compositions and methods of use)
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
FI102075B1 (fi) Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit
DE69324359D1 (de) Verbessertes verfahren zur herstellung von endotoxinbindungsproteinen
DK0431541T3 (da) Toxoplasma gondii-antigener, deres fremstilling og deres anvendelse
DK0434605T3 (da) Ny fremgangsmåde til fremstilling af ikke-fusioneret protein i E.coli
KR910021477A (ko) 인체 단백질 c의 글리코실화 돌연변이체의 발현을 위한 벡터 및 화합물
KR860002526A (ko) 단백질의 상호 분리 방법
GR3007031T3 (da)
GR3007909T3 (da)
RU2336279C2 (ru) БЕЛОК IFNAB-BPI, ЕГО ПРЕДШЕСТВЕННИК, МОЛЕКУЛА ДНК, ЭКСПРЕССИРУЮЩИЙ ВЕКТОР, СПОСОБ ПРОДУЦИРОВАНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ИНГИБИРОВАНИЯ АКТИВНОСТИ IFN-α ИЛИ IFN-β
DK193187A (da) Interferoninduceret humanprotein paa ren form, dets fremstilling og anvendlese
DK0876610T3 (da) Fremgangsmåde og anvendelse af polypeptid i sædcelle-æg-binding til at foröge eller mindske fertilitet
Maekawa et al. Isolation of 110K actin binding protein from mammalian brain and its immunocytochemical localization within cultured cells
Lane et al. Multiple forms of α2u, a sex-dependent urinary protein of the adult male rat
Mendel-Hartvig et al. Studies on beef heart ubiquinol-cytochrome c reductase. Quantification and distribution of the core proteins as determined by radioimmunoassay
Ishaq et al. Purification and identification of antigenic polypeptides of Sm and RNP antigens of goat liver
Mohr et al. Antibodies to interleukin-2 (IL-2) in patients: cross reactivity with different IL-2 species
Callahan et al. Rat Cell Surface Antigens: II. Isolation of a Minor Histocompatibility Antigen

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed